Molijon, Mc Zyrel .

HRN: 25-58-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2024
CEFUROXIME 750MG (VIAL)
07/27/2024
08/03/2024
IV
400mg
Q8
Pcap
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: